Literature DB >> 24732015

Comparison of magnetic resonance and balloon enteroscopic examination of the small intestine in patients with Crohn's disease.

Kento Takenaka1, Kazuo Ohtsuka1, Yoshio Kitazume2, Masakazu Nagahori1, Toshimitsu Fujii1, Eiko Saito1, Makoto Naganuma1, Akihiro Araki1, Mamoru Watanabe3.   

Abstract

BACKGROUND & AIMS: Magnetic resonance (MR) enterography is a recommended imaging technique for detecting intestinal involvement in Crohn's disease (CD). However, the diagnostic accuracy of MR enterography has not been compared directly what that of enteroscopy of the jejunum and proximal ileum. We evaluated the usefulness of MR enterocolonography (MREC) by comparing its findings with those from balloon-assisted enteroscopy.
METHODS: In a prospective study, MREC and enteroscopy were performed within 3 days of each other on 100 patients. Ulcerative lesions and all mucosal lesions were evaluated. Physicians and radiologists were blinded to results from other studies. Findings from MREC were compared directly with those from enteroscopy; the sensitivity and specificity with which MREC detected CD lesions were assessed.
RESULTS: MREC detected ulcerative lesions and all mucosal lesions in the small intestine with 82.4% sensitivity (95% confidence interval [CI], 75.4%-87.7%) and 67.5% sensitivity (95% CI, 63.1%-70.0%); specificity values were 87.6% (95% CI, 83.7%-90.6%) and 94.8% (95% CI, 90.1%-97.5%). MREC detected major stenosis with 58.8% sensitivity (95% CI, 37.6%-77.2%) and 90.0% specificity (95% CI, 88.4%-91.5%) and all stenoses with 40.8% sensitivity (95% CI, 30.8%-49.4%) and 93.7% specificity (95% CI, 91.1%-95.9%).
CONCLUSIONS: MREC is useful for detecting active lesions in the small intestine. However, MR imaging is less sensitive for detecting intestinal damage, such as stenoses. Enteroscopy is preferred for identifying intestinal damage. Suitable imaging approaches should be selected to assess CD lesions in deep small intestine.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnosis; IBD; Intestinal Damage; Ulcer

Mesh:

Year:  2014        PMID: 24732015     DOI: 10.1053/j.gastro.2014.04.008

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  37 in total

1.  Genetic and environmental factors drive personalized medicine for Crohn's disease.

Authors:  Shigeru Oshima; Mamoru Watanabe
Journal:  J Clin Invest       Date:  2018-10-15       Impact factor: 14.808

2.  An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease.

Authors:  F Rieder; D Bettenworth; C Ma; C E Parker; L A Williamson; S A Nelson; G van Assche; A Di Sabatino; Y Bouhnik; R W Stidham; A Dignass; G Rogler; S A Taylor; J Stoker; J Rimola; M E Baker; J G Fletcher; J Panes; W J Sandborn; B G Feagan; V Jairath
Journal:  Aliment Pharmacol Ther       Date:  2018-06-19       Impact factor: 8.171

Review 3.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

Review 4.  Small Bowel Imaging: an Update.

Authors:  Jordi Rimola; Julián Panés
Journal:  Curr Gastroenterol Rep       Date:  2016-07

5.  Comparison of three magnetic resonance enterography indices for grading activity in Crohn's disease.

Authors:  Jordi Rimola; Almudena Alvarez-Cofiño; Tamara Pérez-Jeldres; Carmen Ayuso; Ignacio Alfaro; Sonia Rodríguez; Elena Ricart; Ingrid Ordás; Julián Panés
Journal:  J Gastroenterol       Date:  2016-09-06       Impact factor: 7.527

6.  Colectomy with Permanent End Ileostomy Is More Cost-Effective than Ileal Pouch-Anal Anastomosis for Crohn's Colitis.

Authors:  Sasha Taleban; Martijn G H Van Oijen; Eric A Vasiliauskas; Phillip R Fleshner; Bo Shen; Andrew F Ippoliti; Stephan R Targan; Gil Y Melmed
Journal:  Dig Dis Sci       Date:  2015-10-05       Impact factor: 3.199

7.  Utility of Magnetic Resonance Enterography For Small Bowel Endoscopic Healing in Patients With Crohn's Disease.

Authors:  Kento Takenaka; Kazuo Ohtsuka; Yoshio Kitazume; Katsuyoshi Matsuoka; Masakazu Nagahori; Toshimitsu Fujii; Eiko Saito; Maiko Kimura; Tomoyuki Fujioka; Mamoru Watanabe
Journal:  Am J Gastroenterol       Date:  2017-12-19       Impact factor: 10.864

8.  Magnetic resonance evaluation for small bowel strictures in Crohn's disease: comparison with balloon enteroscopy.

Authors:  Kento Takenaka; Kazuo Ohtsuka; Yoshio Kitazume; Katsuyoshi Matsuoka; Toshimitsu Fujii; Masakazu Nagahori; Maiko Kimura; Tomoyuki Fujioka; Akihiro Araki; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2016-11-15       Impact factor: 7.527

Review 9.  Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Authors:  L Peyrin-Biroulet; W Sandborn; B E Sands; W Reinisch; W Bemelman; R V Bryant; G D'Haens; I Dotan; M Dubinsky; B Feagan; G Fiorino; R Gearry; S Krishnareddy; P L Lakatos; E V Loftus; P Marteau; P Munkholm; T B Murdoch; I Ordás; R Panaccione; R H Riddell; J Ruel; D T Rubin; M Samaan; C A Siegel; M S Silverberg; J Stoker; S Schreiber; S Travis; G Van Assche; S Danese; J Panes; G Bouguen; S O'Donnell; B Pariente; S Winer; S Hanauer; J-F Colombel
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

Review 10.  Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.

Authors:  Hiroshi Nakase; Motoi Uchino; Shinichiro Shinzaki; Minoru Matsuura; Katsuyoshi Matsuoka; Taku Kobayashi; Masayuki Saruta; Fumihito Hirai; Keisuke Hata; Sakiko Hiraoka; Motohiro Esaki; Ken Sugimoto; Toshimitsu Fuji; Kenji Watanabe; Shiro Nakamura; Nagamu Inoue; Toshiyuki Itoh; Makoto Naganuma; Tadakazu Hisamatsu; Mamoru Watanabe; Hiroto Miwa; Nobuyuki Enomoto; Tooru Shimosegawa; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2021-04-22       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.